Search results
Results from the WOW.Com Content Network
Mendelson's syndrome, named in 1946 for American obstetrician and cardiologist Curtis Lester Mendelson, is a form of chemical pneumonitis or aspiration pneumonitis caused by aspiration of stomach contents (principally gastric acid) during anaesthesia in childbirth.
Mendelson's syndrome is a type of chemical pneumonitis. Mineral oil should not be given internally to young children, pets, or anyone with a cough, hiatal hernia, or nocturnal reflux, because it can cause complications such as lipoid pneumonia. [3] Due to its low density, it is easily aspirated into the lungs, where it cannot be removed by the ...
Aspiration pneumonitis (Mendelson's syndrome) is chemical injury of lung tissue secondary to aspiration of regurtitated gastric acid. [15] The syndrome was first described among pregnant patients [ 16 ] after the administration of anesthesia, though it can occur in any scenario where gastric contents are aspirated.
However, responses to different treatments are widely varied, and no single first line treatment represents the default treatment for lymphocytic interstitial pneumonia. References [ edit ]
Lung biopsies performed on patients with NSIP reveal two different disease patterns – cellular and fibrosing – which are associated with different prognoses. The cellular pattern displays chronic inflammation with minimal fibrosis. The fibrosing pattern displays interstitial fibrosis with various inflammation levels.
Bagassosis, an interstitial lung disease, is a type of hypersensitivity pneumonitis attributed to exposure to moldy molasses [1] or bagasse dust. [ 2 ] [ 3 ] Signs and symptoms
Emmonsiosis, also known as emergomycosis, is a systemic fungal infection that can affect the lungs, generally always affects the skin and can become widespread. [1] [2] The lesions in the skin look like small red bumps and patches with a dip, ulcer and dead tissue in the centre.
Ocrelizumab, sold under the brand name Ocrevus, is a medication used for the treatment of multiple sclerosis. It is a humanized anti-CD20 monoclonal antibody. [8] It targets CD20 marker on B lymphocytes and is an immunosuppressive drug. [10] Ocrelizumab binds to an epitope that overlaps with the epitope to which rituximab binds. [10]